Δημοσιεύσεις

Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.

Export 40 results:
Συντάκτης Τίτλος Τύπος [ Έτος(Desc)]
Φίλτρα: Συντάκτης is Panidis, Dimitrios  [Clear All Filters]
2009
Karkanaki, A., Piouka A., Katsikis I., Farmakiotis D., Macut D., & Panidis D. (2009).  Adiponectin levels reflect the different phenotypes of polycystic ovary syndrome: study in normal weight, normoinsulinemic patients.. Fertil Steril. 92(6), 2078-81.
Piouka, A., Farmakiotis D., Katsikis I., Macut D., Gerou S., & Panidis D. (2009).  Anti-Mullerian hormone levels reflect severity of PCOS but are negatively influenced by obesity: relationship with increased luteinizing hormone levels.. Am J Physiol Endocrinol Metab. 296(2), E238-43.
Tsourdi, E., Kourtis A., Farmakiotis D., Katsikis I., Salmas M., & Panidis D. (2009).  The effect of selective estrogen receptor modulator administration on the hypothalamic-pituitary-testicular axis in men with idiopathic oligozoospermia.. Fertil Steril. 91(4 Suppl), 1427-30.
Georgopoulos, N. A., Katsikis I., Florakis D., Panidis D., & Kandarakis E. Diamanti (2009).  Effect of sibutramine on weight reduction and insulin resistance in women with polycystic ovary syndrome.. Fertil Steril. 91(6), e1.
Katsikis, I., Mouslech T., Kourtis A., Panidis D., & Georgopoulos N. A. (2009).  Oligo-ovulation or anovulation and hyperandrogenemia contribute to the decreased serum adiponectin levels in normal-weight women with PCOS with obesity and insulin resistance.. Fertil Steril. 91(4), e3; author reply e4.
2010
Panidis, D., Asteriadis C., Georgopoulos N. A., Katsikis I., Zournatzi V., Karkanaki A., et al. (2010).  Decreased active, total and altered active to total ghrelin ratio in normal weight women with the more severe form of polycystic ovary syndrome.. Eur J Obstet Gynecol Reprod Biol. 149(2), 170-4.
Panidis, D., Tziomalos K., Koiou E., Kandaraki E. A., Tsourdi E., Delkos D., et al. (2010).  The effects of obesity and polycystic ovary syndrome on serum lipocalin-2 levels: a cross-sectional study.. Reprod Biol Endocrinol. 8, 151.
Karkanaki, A., Vavilis D., Traianos A., Kalogiannidis I., & Panidis D. (2010).  Hormone therapy and asymmetrical dimethylarginine in postmenopausal women.. Hormones (Athens). 9(2), 127-35.
Georgopoulos, N. A., Saltamavros A. D., Decavalas G., Piouka A., Katsikis I., & Panidis D. (2010).  Serum AMH, FSH, and LH levels in PCOS.. Fertil Steril. 93(3), e13; author reply e14.
Makedos, A., Goulis D. G., Papanikolaou A., & Panidis D. (2010).  Serum high-sensitivity C-reactive protein and homocysteine changes during hormonal therapy in women with polycystic ovary syndrome: a prospective, matched study.. Angiology. 61(6), 595-601.
Christopoulos, P., Mastorakos G., Gazouli M., Deligeoroglou E., Katsikis I., Diamanti-Kandarakis E., et al. (2010).  Study of association of IRS-1 and IRS-2 genes polymorphisms with clinical and metabolic features in women with polycystic ovary syndrome. Is there an impact?. Gynecol Endocrinol. 26(9), 698-703.
2011
Koiou, E., Tziomalos K., Katsikis I., Kalaitzakis E., Kandaraki E. A., Tsourdi E. A., et al. (2011).  Circulating platelet-derived microparticles are elevated in women with polycystic ovary syndrome diagnosed with the 1990 criteria and correlate with serum testosterone levels.. Eur J Endocrinol. 165(1), 63-8.
Koiou, E., Tziomalos K., Dinas K., Katsikis I., Kalaitzakis E., Delkos D., et al. (2011).  The effect of weight loss and treatment with metformin on serum vaspin levels in women with polycystic ovary syndrome.. Endocr J. 58(4), 237-46.
Panidis, D., Georgopoulos N. A., Piouka A., Katsikis I., Saltamavros A. D., Decavalas G., et al. (2011).  The impact of oral contraceptives and metformin on anti-Müllerian hormone serum levels in women with polycystic ovary syndrome and biochemical hyperandrogenemia.. Gynecol Endocrinol. 27(8), 587-92.
Koiou, E., Dinas K., Tziomalos K., Toulis K., Kandaraki E. A., Kalaitzakis E., et al. (2011).  The phenotypes of polycystic ovary syndrome defined by the 1990 diagnostic criteria are associated with higher serum vaspin levels than the phenotypes introduced by the 2003 criteria.. Obes Facts. 4(2), 145-50.
Katsikis, I., Karkanaki A., Misichronis G., Delkos D., Kandaraki E. A., & Panidis D. (2011).  Phenotypic expression, body mass index and insulin resistance in relation to LH levels in women with polycystic ovary syndrome.. Eur J Obstet Gynecol Reprod Biol. 156(2), 181-5.
Chatzimeletiou, K., Sioga A., Oikonomou L., Charalampidou S., Kantartzi P., Zournatzi V., et al. (2011).  Semen analysis by electron and fluorescence microscopy in a case of partial hydatidiform mole reveals a high incidence of abnormal morphology, diploidy, and tetraploidy.. Fertil Steril. 95(7), 2430.e1-5.
Panidis, D., Katsikis I., Karkanaki A., Piouka A., Armeni A. K., & Georgopoulos N. A. (2011).  Serum anti-Müllerian hormone (AMH) levels are differentially modulated by both serum gonadotropins and not only by serum follicle stimulating hormone (FSH) levels.. Med Hypotheses. 77(4), 649-53.
Diamanti-Kandarakis, E., Livadas S., Katsikis I., Piperi C., Mantziou A., Aimilia M., et al. (2011).  Serum concentrations of carboxylated osteocalcin are increased and associated with several components of the polycystic ovarian syndrome.. J Bone Miner Metab. 29(2), 201-6.
2012
Spanos, N., Tziomalos K., Macut D., Koiou E., Kandaraki E. A., Delkos D., et al. (2012).  Adipokines, insulin resistance and hyperandrogenemia in obese patients with polycystic ovary syndrome: cross-sectional correlations and the effects of weight loss.. Obes Facts. 5(4), 495-504.
Panidis, D., Tziomalos K., Macut D., Delkos D., Betsas G., Misichronis G., et al. (2012).  Cross-sectional analysis of the effects of age on the hormonal, metabolic, and ultrasonographic features and the prevalence of the different phenotypes of polycystic ovary syndrome.. Fertil Steril. 97(2), 494-500.
Panidis, D., Tziomalos K., Misichronis G., Papadakis E., Betsas G., Katsikis I., et al. (2012).  Insulin resistance and endocrine characteristics of the different phenotypes of polycystic ovary syndrome: a prospective study.. Hum Reprod. 27(2), 541-9.
Koiou, E., Tziomalos K., Dinas K., Katsikis I., Kandaraki E. A., Tsourdi E., et al. (2012).  Plasma plasminogen activator inhibitor-1 levels in the different phenotypes of the polycystic ovary syndrome.. Endocr J. 59(1), 21-9.
Koiou, E., Tziomalos K., Katsikis I., Dinas K., Tsourdi E. A., Kandaraki E. A., et al. (2012).  Plasma von Willebrand factor antigen levels are elevated in the classic phenotypes of polycystic ovary syndrome.. Hormones (Athens). 11(1), 77-85.
Vosnakis, C., Georgopoulos N. A., Armeni A. K., Papadakis E., Roupas N. D., Katsikis I., et al. (2012).  Sibutramine administration decreases serum anti-Müllerian hormone (AMH) levels in women with polycystic ovary syndrome.. Eur J Obstet Gynecol Reprod Biol. 163(2), 185-9.

Σελίδες

Επικοινωνία

Τμήμα Ιατρικής, Πανεπιστημιούπολη ΑΠΘ, T.K. 54124, Θεσσαλονίκη
 

Συνδεθείτε

Το τμήμα Ιατρικής στα κοινωνικά δίκτυα.
Ακολουθήστε μας ή συνδεθείτε μαζί μας.

           

Σύνδεσμοι

 

Το πανεπιστήμιο

 
 

Προσωπικό & Φοιτητές